STOCK MARKET BSE NSE

As India's COVID-19 cases surge, Bangladesh lacks vaccines, faces virus variants

On Saturday, health authorities said that for the first time, a coronavirus variant originally identified in India was found in Bangladesh, without providing further details.

Published: 10th May 2021 12:35 AM  |   Last Updated: 10th May 2021 12:35 AM   |  A+A-

coronavirus

Image used for representational purpose only

By PTI

DHAKA: India's surge in coronavirus cases is having a serious effect on neighbouring Bangladesh, with health experts warning of imminent vaccine shortages just as the country should be stepping up jabs and as more contagious virus variants are beginning to be detected.

On Saturday, health authorities said that for the first time, a coronavirus variant originally identified in India was found in Bangladesh, without providing further details.

For weeks, South African variants have dominated the samples sequenced in Bangladesh.

There are concerns that these versions spread more easily and that first-generation vaccines could be less effective against them.

Experts say that declining infections in Bangladesh over the last two weeks compared to March and early April, for reasons that aren't fully understood, provided the perfect opportunity for the nation to scale up vaccinations.

"However, India has banned the export of vaccines as it grapples with the crisis at home. The Serum Institute of India was supposed to supply 30 million doses, 5 million a month to Bangladesh by June.

But the institute has only supplied 7 million doses and has suspended further shipments since February.

"It's caused a real problem," said Dr A S M Alamgir, a scientist with the government's Institute of Epidemiology, Disease Control and Research.

Fearing shortages, the government late last month stopped allowing people to register for a first vaccine dose, and the administration of second doses is also being hampered.

The densely populated country of 160 million is desperately seeking new avenues for vaccines other than India, and is attempting to produce Russian and Chinese vaccines at home by bringing technology from both countries.

Bangladesh is expecting 500,000 doses of Chinese vaccines next week as a gift from Beijing, and has also sought help from the United States.

Dr Mustafizur Rahman, a scientist of the Dhaka-based International Centre for Diarrheal Disease Research, said threats from new variants remained a big concern, especially when vaccines are not available.

Although the border with India is closed to people, goods continue to cross.

Virus sequencing in Bangladesh, like other countries including the US, has been scant.

This means there could easily be blind spots.

"We can't rule out that the Indian variant would not make a new wave in Bangladesh. We have a porous border with India," Alamgir said.

Since March of last year, when the first COVID-19 case was detected in Bangladesh, the country has reported 770,842 confirmed cases and 11,833 deaths.

A nationwide lockdown has been extended until at least May 16, but many businesses, markets and local transportation remain crowded.

Although intercity travel is banned, tens of thousands are expected to leave the capital of Dhaka for their home villages to celebrate next week's Muslim holiday of Eid ul-Fitr.

"If we fail to maintain safety procedures across the country, the virus will make its natural progression, that's for sure," Alamgir said.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp